Brainstorm Cell Therapeutics Inc. (BCLI) Dividend History

Company News

• BrainStorm to Present Biomarker Insights Supporting NurOwn's Mechanism of Action and Clinical Impact at the 2025 ALS Drug Development Summit

  BrainStorm Cell Therapeutics will present new insights into cerebrospinal fluid biomarkers associated with its investigational cell therapy NurOwn, which is being evaluated in an upcoming Phase 3b trial for amyotrophic lateral sclerosis (ALS).

  Benzinga
• BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

  BrainStorm Cell Therapeutics has been granted an extension by Nasdaq to regain compliance with certain continued listing standards by June 30, 2025. The company is committed to executing its compliance plan and advancing its clinical programs to deliver value to patients and shareholders.

  Benzinga
• Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight

  The cell and gene therapies in rare disorders market is expected to grow significantly by 2034, driven by an increase in approvals and adoption of these treatments, ability to treat a broad array of conditions, and rising prevalence of rare disorders.

  GlobeNewswire Inc.

  Featured Companies: ABEO CAPR EDIT FDMT FOLD OCGN PFE RARE RGNX SGMO
• Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

  Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per share, according to data from Benzinga Pro. Biophytis shares jumped 55.2% to $0.4920 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) shares rose 40% to $3.64 in pre-market trading after jumping 22% on Monday. MediaCo Holding Inc. (NASDAQ: MDIA) shares rose 20.2% to $3.63 in pre-market trading after falling 22% on Monday. On April 4, an SEC filing showed Standard General L.P. reported a 95.2% stake in the company, as of April 1. Destiny Tech100 Inc. (NASDAQ: DXYZ) gained 18.5% to $118.33 in pre-market trading after jumping over 68% on Monday. Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 17.2% to $25.60 in pre-market trading after jumping around 21% on Monday. Addex Therapeutics and funds affiliated with Perceptive ...

  Benzinga

  Featured Companies: ANGH BSGM DXYZ FAAS FCUV HALO MAXN MDIA SNGX WTO
• Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) and Landos Biopharma, reported a definitive agreement under which AbbVie will acquire Landos. Landos Biopharma shares jumped 171.2% to $21.70 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Next.e.GO N.V. (NASDAQ: EGOX) shares jumped 85.8% to $0.0730 after falling around 22% on Friday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares climbed 70.1% to $2.9255 after the company announced a collaboration with Univercells Group on nanoparticle-delivered mRNA vaccines. MicroAlgo Inc. (NASDAQ: MLGO) climbed 34.3% to $5.40 after declining around 5% on Friday. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) gained 32.4% to $3.4690. XTL Biopharmaceuticals recently entered into a binding term sheet to acquire all of the issued and outstanding share capital of Social Proxy. Nkarta, Inc. (NASDAQ: NKTX) gained 23.3% to $11.00 after the company priced $240 million underwritten offering. Target Hospitality Corp. (NASDAQ: TH) jumped 21.3% to $10.82 after the company received a buyout offer from TDR Capital. Swvl Holdings Corp. (NASDAQ: SWVL) rose 21.2% to $11.26. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) surged 21% to $0.6949. Lucid Group, Inc. (NASDAQ: LCID) jumped 18.7% to $3.29 after the company announced a $1 billion investment by an affiliate of PIF. Sagimet Biosciences Inc. (NASDAQ: SGMT) rose 16.9% to $5.27 after the company reported FY results and announced the appointment of Tim Walbert and Paul Hoelscher to its Board of Director. Ocugen, Inc. (NASDAQ: OCGN) jumped 16.4% to $1.9101. The Third Circuit Court of Appeals recently upheld the decision of the Eastern District of Pennsylvania to dismiss with prejudice the consolidated securities class action lawsuits against Ocugen. Flora Growth Corp. (NASDAQ: FLGC) shares gained 15.2% to $1.8206 after surging around 34% on Friday. Forge Global Holdings, Inc. (NYSE: FRGE) shares gained 14.5% to $2.67 after ...

  Benzinga

  Featured Companies: ABBV AEHR AKAN BTM CGC CIFR CMP COOT DYN ESPR FL FLGC FRGE GDRX GME IVVD JWEL LASE LCID LDOS LICN LPRO MASI MLGO MSTR MU NKTX OCGN OKYO OTRK SGMT SINT SLRX SOND STIM SWVL TH URGN VMEO